Conference Coverage

U.S. states, counties with highest Alzheimer’s prevalence rates identified


 

FROM AAIC 2023

Optimal resource distribution

In a comment, Percy Griffin, PhD, director of scientific engagement, Alzheimer’s Association, said the research provides useful information about AD prevalence at the local level.

“We need to understand how specific demographics and characteristics can help explain some of the high prevalence in certain areas.”

Compared with White Americans, Dr. Griffin noted that Black Americans are twice as likely to have AD, and older Hispanic Americans are 1.5 times as likely.

This new data will help pinpoint areas of high risk and high need so that funding, staffing, and other resources for those with AD and other dementias can be optimally distributed, he said.

“It gives us that kind of geographic specificity in terms of the prevalence so we can dig deeper and better allocate resources on a county level,” he added.

The Alzheimer’s Association “is fully committed to working with local agencies and being in the communities to assist them in their efforts to intervene in this disease.”

The study also highlights the need for more research to determine what factors other than age and race – such as potential environmental factors – might affect regional AD prevalence, he said.

The study received funding from the National Institutes of Health. Dr. Rajan and Dr. Griffin reported no relevant financial relationships.

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

Daily multivitamins boost memory in older adults: A randomized trial
Federal Practitioner
Are periodontitis, stroke, and Alzheimer’s disease linked?
Federal Practitioner
Patients with post-COVID cognitive symptoms may have gliosis
Federal Practitioner
Altered gut bacteria a biomarker of preclinical Alzheimer’s?
Federal Practitioner
SSRI improves cognition, major depression in early dementia
Federal Practitioner
No link between PPIs and dementia in new study
Federal Practitioner
Regular napping linked to greater brain volume
Federal Practitioner
No link between heartburn meds and dementia
Federal Practitioner
FDA clears new biomarker assays for early Alzheimer’s detection
Federal Practitioner
Long COVID ‘brain fog’ confounds doctors, but new research offers hope
Federal Practitioner